(Q45129556)

English

Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

0 references

1 reference

based on heuristic

inferred from title

prosthetic valve endocarditis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Staphylococcus epidermidis

object named as

Staphylococcus epidermidis

1 reference

based on heuristic

inferred from title

author name string

de Feiter PW

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

Jacobs JA

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

Jacobs MJ

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

Vink C

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

van der Geest S

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

Scandinavian Journal of Infectious Diseases

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

37

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

173-176

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates.

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Newer treatment options for skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021018

21 January 2018

Identifiers

10.1080/00365540410021018

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15849048

reason for deprecated rank

incorrect identifier value

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45129556&oldid=2066678995"